Market Research Logo

RXi Pharmaceuticals Corporation - Product Pipeline Review - 2016

RXi Pharmaceuticals Corporation - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘RXi Pharmaceuticals Corporation - Product Pipeline Review - 2016’, provides an overview of the RXi Pharmaceuticals Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by RXi Pharmaceuticals Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of RXi Pharmaceuticals Corporation
  • The report provides overview of RXi Pharmaceuticals Corporation including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses RXi Pharmaceuticals Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features RXi Pharmaceuticals Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate RXi Pharmaceuticals Corporation’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for RXi Pharmaceuticals Corporation
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding RXi Pharmaceuticals Corporation’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


RXi Pharmaceuticals Corporation Snapshot
RXi Pharmaceuticals Corporation Overview
Key Information
Key Facts
RXi Pharmaceuticals Corporation - Research and Development Overview
Key Therapeutic Areas
RXi Pharmaceuticals Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
RXi Pharmaceuticals Corporation - Pipeline Products Glance
RXi Pharmaceuticals Corporation - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
RXi Pharmaceuticals Corporation - Early Stage Pipeline Products
IND/CTA Filed Products/Combination Treatment Modalities
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
RXi Pharmaceuticals Corporation - Drug Profiles
diphencyprone
Product Description
Mechanism of Action
R&D Progress
RXI-109
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotide to Inhibit CTGF for PVR
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotide Inhibiting MDM2 for Retinoblastoma
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotide to Inhibit SOD-1 for ALS
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotide to Inhibit VEGF for Macular Degeneration
Product Description
Mechanism of Action
R&D Progress
RXI-209
Product Description
Mechanism of Action
R&D Progress
bevasiranib sodium
Product Description
Mechanism of Action
R&D Progress
MMP-26051
Product Description
Mechanism of Action
R&D Progress
MMP-26052
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotide to Inhibit Angiopoietin-2 for Retinal Disease and Cancer
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotide to Inhibit HIF-1 Alpha for Retinal Disease and Cancer
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotide to Inhibit ICAM-1 for Retinal Diseases and Cancer
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotides to Inhibit Complement C3 for Ophthalmology
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotides to Inhibit TNF-alpha for Autoimmune Disorders
Product Description
Mechanism of Action
R&D Progress
TRY-26071
Product Description
Mechanism of Action
R&D Progress
TRY-26077
Product Description
Mechanism of Action
R&D Progress
RXi Pharmaceuticals Corporation - Pipeline Analysis
RXi Pharmaceuticals Corporation - Pipeline Products by Target
RXi Pharmaceuticals Corporation - Pipeline Products by Route of Administration
RXi Pharmaceuticals Corporation - Pipeline Products by Molecule Type
RXi Pharmaceuticals Corporation - Pipeline Products by Mechanism of Action
RXi Pharmaceuticals Corporation - Recent Pipeline Updates
RXi Pharmaceuticals Corporation - Dormant Projects
RXi Pharmaceuticals Corporation - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
bevasiranib sodium
RXi Pharmaceuticals Corporation - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
RXi Pharmaceuticals Corporation, Key Information
RXi Pharmaceuticals Corporation, Key Facts
RXi Pharmaceuticals Corporation - Pipeline by Indication, 2016
RXi Pharmaceuticals Corporation - Pipeline by Stage of Development, 2016
RXi Pharmaceuticals Corporation - Monotherapy Products in Pipeline, 2016
RXi Pharmaceuticals Corporation - Phase II, 2016
RXi Pharmaceuticals Corporation - Phase I, 2016
RXi Pharmaceuticals Corporation - IND/CTA Filed, 2016
RXi Pharmaceuticals Corporation - Preclinical, 2016
RXi Pharmaceuticals Corporation - Discovery, 2016
RXi Pharmaceuticals Corporation - Pipeline by Target, 2016
RXi Pharmaceuticals Corporation - Pipeline by Route of Administration, 2016
RXi Pharmaceuticals Corporation - Pipeline by Molecule Type, 2016
RXi Pharmaceuticals Corporation - Pipeline Products by Mechanism of Action, 2016
RXi Pharmaceuticals Corporation - Recent Pipeline Updates, 2016
RXi Pharmaceuticals Corporation - Dormant Developmental Projects,2016
RXi Pharmaceuticals Corporation - Discontinued Pipeline Products, 2016
List of Figures
RXi Pharmaceuticals Corporation - Pipeline by Top 10 Indication, 2016
RXi Pharmaceuticals Corporation - Pipeline by Stage of Development, 2016
RXi Pharmaceuticals Corporation - Monotherapy Products in Pipeline, 2016
RXi Pharmaceuticals Corporation - Pipeline by Top 10 Target, 2016
RXi Pharmaceuticals Corporation - Pipeline by Route of Administration, 2016
RXi Pharmaceuticals Corporation - Pipeline by Molecule Type, 2016
RXi Pharmaceuticals Corporation - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report